Lauren Panco

Strengthening clinical research capabilities in one of the nation’s most densely populated and high-opportunity oncology markets The START Center for Cancer Research (“START”), the world’s largest community-based network of clinical trial sites specializing in early-phase oncology trials, today announced the appointment of Neel Belani, MD, MBA, as Clinical Investigator at START New Jersey. In this […]

Dr. Al Mutar brings deep expertise in gastrointestinal oncology and early-phase clinical trials and will help to expand access to innovative therapies across North Texas The START Center for Cancer Research (“START”), the world’s largest community-based network of clinical trial sites specializing in early-phase oncology trials, today announced the appointment of Salwan Al Mutar, MD,

Partnership will enhance physician awareness of START’s portfolio of trials, streamline referrals, and support patient access to early-phase oncology research The START Center for Cancer Research (“START”), the world’s largest community-based network of clinical trial sites specializing in early-phase oncology trials, today announced a strategic partnership with Trialing, a platform dedicated to connecting physicians and

Dr. Smith will strengthen XenoSTART’s position as a premier drug development partner, translating PDX-driven insights into faster, more confident oncology development decisions. The START Center for Cancer Research (“START”), today announced the appointment of Frank Smith, PhD, MBA, as President of XenoSTART, its preclinical business unit. In this role, Dr. Smith will oversee XenoSTART’s operations,

Dr. Hafez will lead the new early-phase research site at Los Angeles Cancer Network, one of the nation’s largest and most diverse community-based oncology practices The START Center for Cancer Research (“START”), the world’s largest community-based network specializing in early-phase oncology trials, today announced the appointment of Navid Hafez, MD, MPH, as Director of Clinical